THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
ONWARD MEDICAL BV EO -,12 63E NL0015000HT4 BAW/UFN
© 2024 Xetra Newsboard
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,690 | 5,060 | 21.12. |
XFRA 63E: AUSSETZUNG/SUSPENSION
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
ONWARD MEDICAL BV EO -,12 63E NL0015000HT4 BAW/UFN
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | ONWARD Medical NV: ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World's First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
ARC-EX System is the first and only FDA approved technology... ► Artikel lesen | |
| 12.12. | ONWARD Medical NV: ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability | EcoVadis silver medal recognizes Company's environmental and social impact
Demonstrates ongoing commitment to integrating sustainable business practices
EINDHOVEN, the Netherlands, Dec. 12,... ► Artikel lesen | |
| 26.11. | ONWARD Medical NV: ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights | Raised EUR 50 million in new capital with cornerstone investment from Ottobock, now the Company's top investor
Signed exclusive license with CEA to develop and commercialize WIMAGINE Brain-Computer... ► Artikel lesen | |
| 19.11. | ONWARD Medical NV: ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke | Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and artificial intelligence (AI) technology to restore thought-driven movement after stroke
Funding... ► Artikel lesen | |
| 12.11. | ONWARD Medical NV: ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights | Company to provide update on significant milestones and near-term plans, including its recent successful financing and agreements with Ottobock and CEAEINDHOVEN, the Netherlands, Nov. 12, 2024 (GLOBE... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen.
Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen
Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu
verstehen sein kann.
